The Department of Veterans Affairs has built one of America’s most comprehensive clinical healthcare data review projects with its Evidence Synthesis Program (ESP). Hear from ESP co-founder Dr. Mark Helfand on how the program has been instrumental in advancing treatment for a range of conditions, and has recently taken a forefront role in helping clinicians nationwide better manage COVID-19 emergency care and save lives amidst the pandemic.
HealthCast
Season 2
Episode 32
29m listen
How VA is Using Clinical Review to Fight COVID
Share
The agency’s Evidence Synthesis Program analyzes large quantities of clinical data to better understand common conditions and provide more effective care to VA patients.
-
Dr. Mark Helfand Evidence Based Practice Center Lead VHA
Related Content
-
NIH Leader: AI Must Do the Right Thing, Not Just Do It Right
NIH's Joe Croghan discusses AI ethics, human oversight, risk management and how the Biogenesis initiative could accelerate biomedical research.
7m watch -
How Edge AI Is Shaping the Future of Federal Missions
HP's Leif Olson discussed how edge AI can help federal agencies strengthen security, control costs and improve mission efficiency.
9m watch -
AI Drives Cybersecurity Strategies Beyond Patching to Thwart Vulnerabilities
NinjaOne's Egon Rinderer discussed how AI-driven cyber threats are changing vulnerability management and why agencies need to move beyond patching.
20m watch -
How Zero Trust Can Help Agencies Secure Emerging AI Capabilities
Island's Monty Montgomery discussed how zero trust can help federal agencies secure AI systems and manage emerging risks.
6m watch